Who
Gavin Hattersley
Director
Company insider
Files Form 4 as: Director, McCormick & Company; Director, Zoetis; President & CEO, Molson Coors Beverage.
In numbers
- Trades disclosed
- 84
- Buys
- 2
- Sells
- 2
- Bought
- $257K
- Sold
- $6.1M
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 2 Jul 2012
- Last trade
- 2 Oct 2026
- Last filed
- 5 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Oct 2026filed 5 Oct 2026 | MKC McCormick & CompanyFood Products | SEC FORM 4 Bought | $45K1,000 at $44.61 | filing |
| 10 Apr 2026filed 13 Apr 2026 | MKC McCormick & CompanyFood Products | SEC FORM 4 Bought | $106K2,000 at $52.98 | filing |
| 10 Apr 2026filed 13 Apr 2026 | MKC McCormick & CompanyFood Products | SEC FORM 4 Bought | $106K2,000 at $52.98 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code M | —1,619 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code J | $61K481 at $127.28 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —1,619.333 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —1,619.33 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code M | —1,619 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code J | $61K481 at $127.28 | filing |
| 18 Feb 2026filed 19 Feb 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —1,936 at $0.00 | filing |
| 18 Feb 2026filed 19 Feb 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —1,936 at $0.00 | filing |
| 6 Feb 2026filed 9 Feb 2026 | MKC McCormick & Companyoption or derivative · Food Products | SEC FORM 4 Code A | —2,598 at $0.00 | filing |
| 6 Feb 2026filed 9 Feb 2026 | MKC McCormick & Companyoption or derivative · Food Products | SEC FORM 4 Code A | —2,598 at $0.00 | filing |
| 1 Feb 2026filed 3 Feb 2026 | MKC McCormick & CompanyFood Products | SEC FORM 4 Code A | $25K406 at $61.67 | filing |
| 1 Feb 2026filed 3 Feb 2026 | MKC McCormick & CompanyFood Products | SEC FORM 4 Code A | $25K406 at $61.67 | filing |
| 1 Apr 2025filed 2 Apr 2025 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —1,451.51 | filing |
| 1 Apr 2025filed 2 Apr 2025 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code M | —1,451 | filing |
| 5 Mar 2025filed 7 Mar 2025 | TAP Molson Coors Beverageoption or derivative · Beverages | SEC FORM 4 Code A | —145,430 at $0.00 | filing |
| 5 Mar 2025filed 7 Mar 2025 | TAP Molson Coors BeverageBeverages | SEC FORM 4 Code A | —37,943 at $0.00 | filing |
| 28 Feb 2025filed 4 Mar 2025 | TAP Molson Coors BeverageBeverages | SEC FORM 4 Code F | $778K12,686 at $61.29 | filing |
News
McCormick & Company, Incorporated (NYSE:MKC) Stock Price Up 3.7% – Time to Buy?MKC · dailypolitical.com · 20 Oct 2026McCormick & Company, Incorporated (NYSE:MKC) Stock Jumps 2.1% – What's Next?MKC · dailypolitical.com · 15 Oct 2026
0 headlines in the last 90 days name Gavin Hattersley; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.